Table 3.

Intracranial hemorrhage by patient across time, by 90-day outcome

Patient ID	90-day mRS	Bleed at baseline	Bleed <24 h	Bleed >24 h	Any new bleed
18	0	No	No	No	None
3	1	No	HI2	HI2	HI2
9	1	No	No	No	None
10	1	No	No	No	None
11	1	No	No	No	None
21	1	HI1*	HI1*	HI1*	HI1
22	1	No	No		None
23	1	No	No	HI1 (9d).	HI1
24	1	No	No	HI1 (4d)	HI1
5	2	No	No	No	None
6	2	HI1†	HI1†	HI1†	None
20	2	No	No	No	None
7	3	No	No	HI1 (4d)	HI1
16	3	No	No	No	None
25	3	No	HI1	HI1	HI1
1	4	No	HI2	HI2	HI2
2	4	No	No	HI1 (3d)	HI1
13	4	No	HI1	HI1	HI1
15	4	No	HI1	HI1	HI1
14	5	No	HI1	PH1 (2d)	PH1
17	6 (d 3)	No	No		None
4	6 (d 10)	No	No	HI2 (7d)‡	HI2‡
8	6 (d 13)	No	No	No	None
12	6 (d 37)	No	No	No	None

Italicized items represent CT-confirmed assessments; nonitalicized are MR GRE only; blank indicates no assessments completed during follow-up period. See Table 4 for abbreviations of bleed types. Day of scan showing >24 h bleed is in parentheses after bleed type. mRS scoring: 0 = no deficits, 6 = death, with days to death in parentheses.

^*Two microbleeds (MR) present at baseline (up to four allowed by protocol); new HI1 present within 24 h.

^†One microbleed (MR) present at baseline (up to four allowed by protocol) and did not change; no new bleed.

^‡HI2 in new infarct at day 7.